IRIS PubliCatt

Fargnoli, Maria Concetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.153
EU - Europa 725
AS - Asia 59
AF - Africa 25
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 1.977
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.146
SE - Svezia 279
IE - Irlanda 124
IT - Italia 94
DE - Germania 76
BE - Belgio 41
CN - Cina 35
GB - Regno Unito 35
CI - Costa d'Avorio 23
FR - Francia 16
FI - Finlandia 12
RU - Federazione Russa 11
UA - Ucraina 10
CH - Svizzera 9
IN - India 8
CA - Canada 7
NL - Olanda 5
RO - Romania 5
BR - Brasile 3
JP - Giappone 3
PE - Perù 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
AU - Australia 2
ES - Italia 2
EU - Europa 2
IR - Iran 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GH - Ghana 1
GR - Grecia 1
HK - Hong Kong 1
ID - Indonesia 1
PH - Filippine 1
SG - Singapore 1
TW - Taiwan 1
VN - Vietnam 1
Totale 1.977
Salva come PNG Salva come JPEG
Città #
Chandler 407
Dublin 124
Ann Arbor 98
Boston 52
Bremen 52
Princeton 51
San Mateo 44
Brussels 41
Wilmington 30
Abidjan 23
Woodbridge 17
Beijing 14
Cattolica 14
Ashburn 11
Jacksonville 10
Rome 10
Nanjing 9
Boydton 8
Helsinki 8
London 8
Mountain View 8
Redwood City 8
Dearborn 6
Houston 6
Norwalk 6
Fairfield 5
Milan 5
Augusta 4
Changsha 4
Clearwater 4
Dallas 4
Padova 4
Toronto 4
Amsterdam 3
Chicago 3
Detroit 3
Edinburgh 3
La Spezia 3
Lausanne 3
Leawood 3
Lima 3
Marburg 3
Nanchang 3
North Charleston 3
Paris 3
Regensdorf 3
Auckland 2
Bologna 2
Cambridge 2
Campagna 2
Castelnuovo Rangone 2
Comelico Superiore 2
Duncan 2
Esslingen am Neckar 2
Fort Worth 2
Fremont 2
Guglionesi 2
Hebei 2
Lawrence 2
Madrid 2
Monmouth Junction 2
New Delhi 2
Perugia 2
Redmond 2
Sacramento 2
San Francisco 2
Slough 2
Teramo 2
Timisoara 2
Vienna 2
Zurich 2
Andover 1
Arezzo 1
Athens 1
Berlin 1
Bern 1
Boardman 1
Bottrop 1
Brierley Hill 1
Brookeville 1
Cairo 1
Catania 1
Chiswick 1
Cittadella 1
Conshohocken 1
Cupertino 1
Fiumicino 1
Hanoi 1
Hong Kong 1
Hunedoara 1
Jakarta 1
Jiaxing 1
Kamampa 1
Kuala Lumpur 1
Kulim 1
Kyiv 1
Köln 1
L'aquila 1
Lappeenranta 1
Logan 1
Totale 1.217
Salva come PNG Salva come JPEG
Nome #
Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study 106
Cutaneous squamous cell carcinoma. Italian guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines 103
A new dermoscopic algorithm for the differential diagnosis of facial lentigo maligna and pigmented actinic keratosis 93
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 66
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy 59
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments 51
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma 50
ΜelanoQ: A Consensus Questionnaire of Standardized Epidemiologic and Clinical Variables for Melanoma Risk Assessment by the MelaNostrum Consortium 50
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations 46
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 43
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 43
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study 43
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics – Update 2019 43
Management of cutaneous melanoma: Comparison of the leading international guidelines updated to the 8th American Joint Committee on Cancer staging system and workup proposal by the Italian Society of Dermatology 43
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 43
Pruritus characteristics in a large Italian cohort of psoriatic patients 43
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 42
5-aminolaevulinic acid patch photodynamic therapy for the treatment of actinic keratoses: preliminary results from an italian study in the real-life setting 41
A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic 39
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention 38
Comment on ‘Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines’ 37
Sclerosing nevus with pseudomelanomatous features: dermoscopic and confocal aspects 37
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility 36
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study 36
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019 34
Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp 32
Italian expert consensus paper on the management of patients with actinic keratoses 32
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 32
Molecular alterations in basal cell carcinoma subtypes 32
Clinical determinants of complete response to vismodegib in locally advanced basal cell carcinoma: a multicentre experience 32
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 31
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 31
Response to: Comment on ‘Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines’ 30
Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018)) 29
Real-world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study 28
Contribution of common genetic variants to familial aggregation of disease and implications for sequencing studies 27
Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family 27
Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognition 27
Dermoscopic similarity is an independent predictor of BRAF mutational concordance in multiple melanomas 25
Psoriasis and its management in women of childbearing age: Tools to increase awareness in dermatologists and patients 25
Assessing the beneficial impact of a patient support program in secukinumab-treated patients with psoriasis in italy 25
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities 24
Satisfaction and attitudes toward systemic treatments for psoriasis: A cross-sectional study 24
Treatment adherence with diclofenac 3% gel among patients with multiple actinic keratoses: an integrated low-intensity intervention program versus standard-of-care 22
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma 22
Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas 21
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real-life multicenter prospective observational cohort study 21
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience 19
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 19
Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics 18
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 18
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis 13
The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients 12
Advanced Cutaneous Squamous Cell Carcinoma: Italian Multicentric Retrospective Analysis of Patient Profiles and Therapeutic Approaches 12
Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls 12
Telomeres and telomerase in cutaneous squamous cell carcinoma 12
Self-Assessment Questionnaire on Patient-Physician Concordance on Nevus Self-Count and Models Development to Predict High-Risk Phenotype >50 Nevi 10
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation 6
Update on the Management of Pediatric Psoriasis: An Italian Consensus 6
Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – Update 2022 5
The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe 5
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study (Archives of Dermatological Research, (2022), 314, 6, (593-603), 10.1007/s00403-021-02243-w) 5
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022 4
Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN Study 4
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022 4
null 3
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement 3
The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients 3
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023 2
AtopyReg®: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST 2
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study 2
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference 1
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference 1
Mycosis fungoides: creation of a prospective, interdisciplinary and multicenter study in central Italy 1
Clinical characteristics of an Italian patient population with advanced BCC and real-life evaluation of HHI safety and effectiveness 1
High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium 1
Totale 2.068
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.596
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201953 0 0 19 2 2 3 5 7 0 4 11 0
2019/202091 14 5 8 5 6 1 7 14 7 7 14 3
2020/2021141 3 11 2 3 6 5 16 44 9 7 29 6
2021/2022438 15 8 8 17 29 8 1 64 32 34 108 114
2022/20231.005 109 130 71 177 77 118 29 87 142 16 38 11
2023/2024269 24 200 45 0 0 0 0 0 0 0 0 0
Totale 2.068